Amphotericin B lipid complex for the treatment of presumed or confirmed fungal infections in immunocompromised patients with hematologic malignancies

Keyphrases

• Hematological Malignancies 100%
• Fungal Infection 100%
• Complete Response 100%
• Amphotericin B Lipid Complex 100%
• Infections In Immunocompromised Hosts 100%
• Renal Disease 66%
• % Response 66%
• Partial Response 66%
• Amphotericin B 66%
• Chemotherapy 33%
• Renal Function 33%
• Treatment Course 33%
• High Dose 33%
• Overall Response Rate 33%
• Allograft 33%
• Daily Dose 33%
• Adult Patients 33%
• Pneumonia 33%
• Response Rate 33%
• Toxicity Profile 33%
• Serum Creatinine 33%
• Aspergillus 33%
• Autograft 33%
• Antifungal Therapy 33%
• Fluconazole 33%

Medicine and Dentistry

• Mycosis 100%
• Hematologic Malignancy 100%
• Amphotericin B Lipid Complex 100%
• Infection in Immunocompromised Patients 100%
• Amphotericin 25%
• Drug Megadose 12%
• Aspergillus 12%
• Allograft 12%
• Autograft 12%
• Creatinine 12%
• Infection 12%
• Kidney Function 12%
• Antifungal Therapy 12%
• Fluconazole 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Hematologic Malignancy 100%
• Immunocompromised Patient 100%
• Amphotericin B Lipid Complex 100%
• Mycosis 100%
• Amphotericin 25%
• Chemotherapy 12%
• Antifungal Therapy 12%
• Infection 12%
• Creatinine 12%
• Aspergillus 12%
• Fluconazole 12%